Sutimlimab suppresses SARS-CoV-2 mRNA vaccine-induced hemolytic crisis in a patient with cold agglutinin disease

This report suggests that appropriate sutimlimab administration can suppress SARS-CoV-2 mRNA vaccination-induced CAD exacerbation, and that it could be a preventive strategy to minimize hemolytic attacks in susceptible populations.PMID:38148014 | PMC:PMC10861374 | DOI:10.3960/jslrt.23040
Source: Journal of Clinical and Experimental Hematopathology : JCEH - Category: Hematology Authors: Source Type: research